Inhibition of growth and respiration of Leishmania mexicana by the antitumor agent lonidamine.
1. The antitumor drug lonidamine inhibited growth of promastigotes of Leishmania mexicana in axenic culture. 2. Fifty percent inhibition was attained at 0.42 mM, and was reflected mainly in an increase in lag time, with less effect on final cell yield. 3. The drug was leishmanistatic, since when a non-growing culture in the presence of 0.5 mM lonidamine was centrifuged and the cells resuspended in fresh medium, growth started and reached the control value. 4. Both coupled and FCCP-uncoupled respiration of intact promastigotes were inhibited by lonidamine; 50% inhibition was attained at 0.5 and 0.4 mM, respectively. 5. The results suggested that the mechanism of inhibition of growth of L. mexicana is, as proposed in the case of Trypanosoma cruzi epimastigotes and Trypanosoma brucei procyclic trypomastigotes, through inhibition of the energy metabolism.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone / Q000494:pharmacology; D007191:Indazoles / Q000494:pharmacology*; D007700:Kinetics; D007894:Leishmania mexicana / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects*; D011720:Pyrazoles / Q000494:pharmacology*
D000970:Antineoplastic Agents; D000981:Antiprotozoal Agents; D007191:Indazoles; D011720:Pyrazoles; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; C016371:lonidamine